Generic Entry. The royalty rates set forth in part 4.1 of this Fee Schedule that are applied to the Net Revenue of a Product in a country shall be reduced by […***…]% if a Generic Product in respect of that Product is sold in such country, beginning in the first Quarter during which such Generic Product is sold in such country.
Appears in 2 contracts
Sources: Licence Agreement (Acadia Pharmaceuticals Inc), Licence Agreement (Acadia Pharmaceuticals Inc)
Generic Entry. The royalty rates set forth in part 4.1 clauses 4.4 of this Fee Schedule that are applied to the Net Revenue of a NNZ‑2591 Product in a country shall be reduced by […***…]% if a Generic Product in respect of that NNZ‑2591 Product is sold in such country, beginning in the first Quarter during which such Generic Product is sold in such country.
Appears in 1 contract
Sources: Joint Venture and Licence Agreement (Acadia Pharmaceuticals Inc)